CeriBell, Inc. (CBLL)

-2.98% (1D)

Market Cap	701.58M
Revenue (ttm)	65.44M
Net Income (ttm)	-40.46M
Shares Out	35.87M
EPS (ttm)	-3.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	109,279
Open	20.33
Previous Close	20.16
Day's Range	19.51 - 20.21
52-Week Range	18.69 - 32.75
Beta	n/a
Analysts	Strong Buy
Price Target	33.25 (+69.99%)
Earnings Date	May 14, 2025

About CBLL

CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders designed to record and store EEG signals generated...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 11, 2024
• Employees: 281
• Stock Exchange: NASDAQ
• Ticker Symbol: CBLL
• Website: https://www.ceribell.com

Financial Performance

In 2024, CeriBell's revenue was $65.44 million, an increase of 44.71% compared to the previous year's $45.23 million. Losses were -$40.46 million, 37.3% more than in 2023.

Financial numbers in USD

Analyst Forecast

According to 5 analysts, the average rating for CBLL stock is "Strong Buy." The 12-month stock price forecast is $33.25, which is an increase of 69.99% from the latest price.

Price Target

$33.25

(69.99% upside)

Analyst Consensus: Strong Buy